The association of resistin with metabolic disease is not limited to obesity or T2DM, it is associated with CVDs, hypertension, atherosclerosis, arthritis, and various malignancies (Filková et al., 2009). Here, RETN is linked to obesity due to melanocortin 4 receptor deficiency.